BioMedicalRx 🧬 🇺🇸 ✝️ (@biomedicalrx) 's Twitter Profile
BioMedicalRx 🧬 🇺🇸 ✝️

@biomedicalrx

Life Science investor. No tweets should be construed as investment advice. God is the great physician and healer of all.

ID: 1381423457842331651

calendar_today12-04-2021 01:46:44

17,17K Tweet

4,4K Followers

512 Following

BioMedicalRx 🧬 🇺🇸 ✝️ (@biomedicalrx) 's Twitter Profile Photo

$XBI $ARKG 🇺🇸 🧬 💊 🧪 #MABA 🔥 The biotech winter may have quietly ended and the next wave of revolution may be upon us. 👏 Robert F. Kennedy Jr Dr. Marty Makary Vinay Prasad MD MPH Leadership and vision matter. The future is looking very bright

$XBI $ARKG 🇺🇸 🧬 💊 🧪 

#MABA 🔥 

The biotech winter may have quietly ended and the next wave of revolution may be upon us.  

👏 <a href="/RobertKennedyJr/">Robert F. Kennedy Jr</a> <a href="/DrMakaryFDA/">Dr. Marty Makary</a> <a href="/VPrasadMDMPH/">Vinay Prasad MD MPH</a>  
Leadership and vision matter. The future is looking very bright
BioMedicalRx 🧬 🇺🇸 ✝️ (@biomedicalrx) 's Twitter Profile Photo

Recent nice inside buying $PRME Nice to see some insiders with a spine . So many stocks are down 80 to 90% in this sector yet insiders have been quiet, WEAKNESS Not the case here. Oh yeah, the most recent inside buying is from arguably one of the greatest scientist ever. Not

Recent nice inside buying $PRME 
Nice to see some insiders with a spine . So many stocks are down 80 to 90% in this sector yet insiders have been quiet, WEAKNESS 

Not the case here. Oh yeah, the most recent inside buying is from arguably one of the greatest scientist ever. Not
Biotech2k (@biotech2k1) 's Twitter Profile Photo

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression finance.yahoo.com/news/sana-biot…

J Keynes (@jkeynesalpha) 's Twitter Profile Photo

$PRME is the main U.S. company that now will compete with Chinese innovation in the frontiers of gene editing; competition is heating up now. Next years will be huge for $PRME. Secretary Kennedy and Dr. Marty Makary are right to unshackle our U.S. gene editing companies from red tape